Fox Chase Cancer Center News

PHILADELPHIA (May 26, 2022)—In a study published in the prestigious journal Nature, Fox Chase Cancer Center researchers have shown that a drug candidate may help re-initiate immune responses by mimicking influenza virus infections in patients whose cancer is unresponsive to immunotherapy.

PHILADELPHIA (May 25, 2022)—Laura Bukavina, MD, MPH, a Urologic Oncology Fellow at Fox Chase Cancer Center, has been awarded a 2022 Urology Care Foundation Research Scholar Award, which supports future research leaders and ensures they receive the necessary training and guidance for a successful research career. The Urology Care Foundation is the official foundation of the American Urological Association (AUA).

PHILADELPHIA (May 10, 2022)—In a study published today in the prestigious journal Cancer Research, Fox Chase Cancer Center researchers analyzed over 700 experimentally determined structures of the high-priority cancer targets KRAS, NRAS, and HRAS to facilitate drug discovery for these proteins.

PHILADELPHIA (April 29, 2022)—Christian A. Koch, MD, PhD, FACP, MACE, professor and director of the Division of Endocrinology at Fox Chase Cancer Center, has been appointed as a senior editor for Endocrinology, Diabetes & Metabolism Case Reports (EDM). He has also joined the editorial board for the Journal of the Endocrine Society (JES).

PHILADELPHIA (April 28, 2022)—Researchers at Fox Chase Cancer Center and Temple University Hospital will participate in a $3 million multisite study on the use of telehealth for lymphedema management in head and neck cancer survivors.

PHILADELPHIA (April 26, 2022)—The Pennsylvania Medical Society (PAMED) announced its 2022 Top Physicians Under 40 award recipients. Two Fox Chase Cancer Center doctors were honored: Kristen Manley, MD, division chief of the Section of Hospitalist Service and associate professor in the Department of Medicine, and Jason Castellanos, MD, MS, assistant professor in the Department of Surgical Oncology.

PHILADELPHIA (April 25, 2022) — Zachary Frosch, MD, MSHP, an assistant professor in the Department of Hematology/Oncology and a member of the Cancer Prevention and Control research program at Fox Chase Cancer Center, has received a Young Investigator Award (YIA) from the National Comprehensive Cancer Network (NCCN) and the NCCN Foundation.

PHILADELPHIA (April 25, 2022)— Fifty-two Fox Chase Cancer Center physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2022. Physicians on the list were nominated by a national survey of their professional peers.